SEK 0.13
(-2.03%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 5.2 Million SEK | -17.46% |
2022 | 6.3 Million SEK | 117.24% |
2021 | 2.9 Million SEK | -25.64% |
2020 | 3.9 Million SEK | -33.9% |
2019 | 5.9 Million SEK | 110.71% |
2018 | 2.8 Million SEK | 0.0% |
2017 | - SEK | -100.0% |
2016 | 1.16 Million SEK | 0.0% |
2015 | - SEK | 0.0% |
2014 | - SEK | 0.0% |
2013 | - SEK | 0.0% |
2012 | - SEK | 0.0% |
2011 | - SEK | 0.0% |
2010 | - SEK | 0.0% |
2009 | - SEK | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q2 | 3.9 Million SEK | -17.02% |
2024 Q3 | 2.9 Million SEK | -20.51% |
2024 Q1 | 4.7 Million SEK | -9.62% |
2023 Q4 | 5.2 Million SEK | -21.21% |
2023 Q3 | 6.6 Million SEK | -16.46% |
2023 Q2 | 7.9 Million SEK | 0.0% |
2023 FY | 5.2 Million SEK | -17.46% |
2023 Q1 | 7.9 Million SEK | 25.4% |
2022 FY | 6.3 Million SEK | 117.24% |
2022 Q4 | 6.3 Million SEK | 10.53% |
2022 Q3 | 5.7 Million SEK | -9.52% |
2022 Q2 | 6.3 Million SEK | -7.35% |
2022 Q1 | 6.8 Million SEK | 134.48% |
2021 Q1 | 3.3 Million SEK | -15.38% |
2021 FY | 2.9 Million SEK | -25.64% |
2021 Q3 | 2.8 Million SEK | 0.0% |
2021 Q4 | 2.9 Million SEK | 3.57% |
2021 Q2 | 2.8 Million SEK | -15.15% |
2020 Q3 | 4.5 Million SEK | -8.16% |
2020 Q4 | 3.9 Million SEK | -13.33% |
2020 FY | 3.9 Million SEK | -33.9% |
2020 Q2 | 4.9 Million SEK | -12.5% |
2020 Q1 | 5.6 Million SEK | -5.08% |
2019 Q1 | 9.7 Million SEK | 246.43% |
2019 Q2 | 6.9 Million SEK | -28.87% |
2019 Q3 | 6.4 Million SEK | -7.25% |
2019 Q4 | 5.9 Million SEK | -7.81% |
2019 FY | 5.9 Million SEK | 110.71% |
2018 Q2 | - SEK | 0.0% |
2018 FY | 2.8 Million SEK | 0.0% |
2018 Q4 | 2.8 Million SEK | -34.88% |
2018 Q3 | 4.3 Million SEK | 0.0% |
2018 Q1 | - SEK | 0.0% |
2017 Q3 | - SEK | 0.0% |
2017 FY | - SEK | -100.0% |
2017 Q4 | - SEK | 0.0% |
2017 Q2 | - SEK | 0.0% |
2017 Q1 | - SEK | -100.0% |
2016 Q3 | - SEK | 0.0% |
2016 Q4 | 1.16 Million SEK | 0.0% |
2016 FY | 1.16 Million SEK | 0.0% |
2016 Q1 | - SEK | -100.0% |
2016 Q2 | - SEK | 0.0% |
2015 Q4 | 1.05 Million SEK | 0.0% |
2015 Q1 | - SEK | 0.0% |
2015 FY | - SEK | 0.0% |
2015 Q3 | - SEK | 0.0% |
2015 Q2 | - SEK | 0.0% |
2014 Q1 | - SEK | 0.0% |
2014 FY | - SEK | 0.0% |
2014 Q4 | - SEK | 0.0% |
2014 Q3 | - SEK | 0.0% |
2014 Q2 | - SEK | 0.0% |
2013 Q2 | - SEK | 0.0% |
2013 Q1 | - SEK | 0.0% |
2013 Q3 | - SEK | 0.0% |
2013 Q4 | - SEK | 0.0% |
2013 FY | - SEK | 0.0% |
2012 Q2 | - SEK | 0.0% |
2012 Q1 | - SEK | 0.0% |
2012 FY | - SEK | 0.0% |
2012 Q4 | - SEK | 0.0% |
2012 Q3 | - SEK | 0.0% |
2011 Q3 | - SEK | 0.0% |
2011 Q2 | - SEK | 0.0% |
2011 Q1 | - SEK | 0.0% |
2011 FY | - SEK | 0.0% |
2011 Q4 | - SEK | 0.0% |
2010 FY | - SEK | 0.0% |
2010 Q4 | - SEK | 0.0% |
2009 FY | - SEK | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
Acarix AB (publ) | - SEK | -Infinity% |
ADDvise Group AB (publ) | 1.61 Billion SEK | 99.678% |
ADDvise Group AB (publ) | 1.61 Billion SEK | 99.678% |
Arcoma AB | 3.87 Million SEK | -34.263% |
Bactiguard Holding AB (publ) | 233.09 Million SEK | 97.769% |
BICO Group AB (publ) | 1.85 Billion SEK | 99.719% |
Boule Diagnostics AB (publ) | 166.1 Million SEK | 96.869% |
CellaVision AB (publ) | 64.7 Million SEK | 91.963% |
Clinical Laserthermia Systems AB (publ) | 454 Thousand SEK | -1045.374% |
Chordate Medical Holding AB (publ) | - SEK | -Infinity% |
C-Rad AB (publ) | 1.8 Million SEK | -188.889% |
Duearity AB (publ) | 10.58 Million SEK | 50.86% |
Dignitana AB (publ) | 19.1 Million SEK | 72.781% |
Getinge AB (publ) | 8.07 Billion SEK | 99.936% |
Scandinavian Real Heart AB (Publ) | 8.24 Million SEK | 36.967% |
Iconovo AB (publ) | 7.72 Million SEK | 32.685% |
Integrum AB (publ) | 6.42 Million SEK | 19.056% |
Luxbright AB (publ) | 206.02 Thousand SEK | -2423.978% |
Mentice AB (publ) | 9.55 Million SEK | 45.59% |
OssDsign AB (publ) | 3.15 Million SEK | -65.079% |
Paxman AB (publ) | 13.57 Million SEK | 61.68% |
Promimic AB (publ) | - SEK | -Infinity% |
Qlife Holding AB (publ) | 20.73 Million SEK | 74.917% |
SciBase Holding AB (publ) | 6.79 Million SEK | 23.496% |
ScandiDos AB (publ) | - SEK | -Infinity% |
Sectra AB (publ) | 31.78 Million SEK | 83.642% |
Sedana Medical AB (publ) | 4.3 Million SEK | -20.762% |
Senzime AB (publ) | 11.46 Million SEK | 54.656% |
SpectraCure AB (publ) | 6.71 Million SEK | 22.584% |
Stille AB | 62.94 Million SEK | 91.738% |
Vitrolife AB (publ) | 2.08 Billion SEK | 99.751% |
Xvivo Perfusion AB (publ) | 31.43 Million SEK | 83.459% |